» Articles » PMID: 18624921

Identification and Characterization of a Novel, Shorter Isoform of the Small Conductance Ca2+ -activated K+ Channel SK2

Overview
Journal J Neurochem
Specialties Chemistry
Neurology
Date 2008 Jul 16
PMID 18624921
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Throughout the CNS, small conductance Ca(2+)-activated potassium (SK) channels modulate firing frequency and neuronal excitability. We have identified a novel, shorter isoform of standard SK2 (SK2-std) in mouse brain which we named SK2-sh. SK2-sh is alternatively spliced at exon 3 and therefore lacks 140 amino acids, which include transmembrane domains S3, S4 and S5, compared with SK2-std. Western blot analysis of mouse hippocampal tissue revealed a 47 kDa protein product as predicted for SK2-sh along with a 64 kDa band representing the standard SK2 isoform. Electrophysiological recordings from transiently expressed SK2-sh revealed no functional channel activity or interaction with SK2-std. With the help of real-time PCR, we found significantly higher expression levels of SK2-sh mRNA in cortical tissue from AD cases when compared with age-matched controls. A similar increase in SK2-sh expression was induced in cortical neurons from mice by cytokine exposure. Substantial clinical evidence suggests that excess cytokines are centrally involved in the pathogenesis of Alzheimer's disease. Thus, SK2-sh as a downstream target of cytokines, provide a promising target for additional investigation regarding potential therapeutic intervention.

Citing Articles

Physiology and Therapeutic Potential of SK, H, and M Medium AfterHyperPolarization Ion Channels.

Dwivedi D, Bhalla U Front Mol Neurosci. 2021; 14:658435.

PMID: 34149352 PMC: 8209339. DOI: 10.3389/fnmol.2021.658435.


Small-conductance calcium-activated potassium type 2 channels (SK2, KCa2.2) in human brain.

Willis M, Trieb M, Leitner I, Wietzorrek G, Marksteiner J, Knaus H Brain Struct Funct. 2016; 222(2):973-979.

PMID: 27357310 PMC: 5334391. DOI: 10.1007/s00429-016-1258-1.


Neuronal expression of the intermediate conductance calcium-activated potassium channel KCa3.1 in the mammalian central nervous system.

Turner R, Kruskic M, Teves M, Scheidl-Yee T, Hameed S, Zamponi G Pflugers Arch. 2014; 467(2):311-28.

PMID: 24797146 DOI: 10.1007/s00424-014-1523-1.


The therapeutic potential of small-conductance KCa2 channels in neurodegenerative and psychiatric diseases.

Lam J, Coleman N, Garing A, Wulff H Expert Opin Ther Targets. 2013; 17(10):1203-20.

PMID: 23883298 PMC: 3778119. DOI: 10.1517/14728222.2013.823161.


Role of the K(Ca)3.1 K+ channel in auricular lymph node CD4+ T-lymphocyte function of the delayed-type hypersensitivity model.

Ohya S, Nakamura E, Horiba S, Kito H, Matsui M, Yamamura H Br J Pharmacol. 2013; 169(5):1011-23.

PMID: 23594188 PMC: 3696325. DOI: 10.1111/bph.12215.